Found: 8
Select item for more details and to access through your institution.
CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 609, doi. 10.1038/leu.2013.354
- By:
- Publication type:
- Article
The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 2, p. 321, doi. 10.1038/leu.2010.253
- By:
- Publication type:
- Article
The CALM–AF10 fusion is a rare event in acute megakaryoblastic leukemia.
- Published in:
- 2007
- By:
- Publication type:
- Letter
MSAP enhances migration of C6 glioma cells through phosphorylation of the myosin regulatory light chain.
- Published in:
- Cellular & Molecular Life Sciences, 2005, v. 62, n. 11, p. 1260, doi. 10.1007/s00018-005-5055-x
- By:
- Publication type:
- Article
THE LANDSCAPE OF DRUG PERTURBATION EFFECTS IN LEUKEMIA AND LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 127, doi. 10.1002/hon.87_2629
- By:
- Publication type:
- Article
EG‐011 IS A NOVEL SMALL MOLECULE WITH IN VITRO AND IN VIVO ANTI‐TUMOR ACTIVITY AGAINST LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 513, doi. 10.1002/hon.197_2631
- By:
- Publication type:
- Article
THE LANDSCAPE OF DRUG PERTURBATION EFFECTS IN LEUKEMIA AND LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 127, doi. 10.1002/hon.87_2629
- By:
- Publication type:
- Article
EG‐011 IS A NOVEL SMALL MOLECULE WITH IN VITRO AND IN VIVO ANTI‐TUMOR ACTIVITY AGAINST LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 513, doi. 10.1002/hon.197_2631
- By:
- Publication type:
- Article